Quinacrine enhances temozolomide cytotoxicity in temozolomide-sensitive and -resistant glioblastoma cells

Quinacrine enhances temozolomide cytotoxicity in temozolomide-sensitive and -resistant glioblastoma cells

Background: The alkylating agent temozolomide (TMZ) is widely used in glioblastoma multiforme (GBM) therapy. Unfortunately, TMZ-resistance frequently occurs in recurrent GBM and is the major cause of treatment failure. The anti-malarial drug quinacrine (QC) harbors antitumor and chemosensitivity pro...

Full description

Bibliographic Details
Main Authors: Pingde Zhang, Ning Li, Karrie Mei Yee Kiang, Zhiyuan Zhu, Gloria Wai Man Leung, Stephen Yin Cheng, Gilberto Ka Kit Leung
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Glioma
Subjects:
Apoptosis
autophagy
glioblastoma multiforme
quinacrine
temozolomide
Online Access:http://www.jglioma.com/article.asp?issn=2589-6113;year=2018;volume=1;issue=5;spage=175;epage=181;aulast=Zhang

Internet

http://www.jglioma.com/article.asp?issn=2589-6113;year=2018;volume=1;issue=5;spage=175;epage=181;aulast=Zhang

Similar Items